David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Neuroethics 4 (2):129-142 (2011)
Deep brain stimulation (DBS) has been proposed as a potential treatment of drug addiction on the basis of its effects on drug self-administration in animals and on addictive behaviours in some humans treated with DBS for other psychiatric or neurological conditions. DBS is seen as a more reversible intervention than ablative neurosurgery but it is nonetheless a treatment that carries significant risks. A review of preclinical and clinical evidence for the use of DBS to treat addiction suggests that more animal research is required to establish the safety and efficacy of the technology and to identify optimal treatment parameters before investigating its use in addicted persons. Severely addicted persons who try and fail to achieve abstinence may, however, be desperate enough to undergo such an invasive treatment if they believe that it will cure their addiction. History shows that the desperation for a cure of addiction can lead to the use of risky medical procedures before they have been rigorously tested. In the event that DBS is used in the treatment of addiction, we provide minimum ethical requirements for clinical trials of its use in the treatment of addiction. These include: restrictions of trials to severely intractable cases of addiction; independent oversight to ensure that patients have the capacity to consent and give that consent on the basis of a realistic appreciation of the potential benefits and risks of DBS; and rigorous assessments of the effectiveness and safety of this treatment compared to the best available treatments for addiction
|Keywords||Addiction Deep brain stimulation Treatment Neurosurgery Neuroethics Consent Coercion|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
Emily Bell & Eric Racine (2010). Deep Brain Stimulation, Ethics, and Society. Journal of Clinical Ethics 21 (2):101.
Adrian Carter & Wayne Hall (2007). The Social Implications of Neurobiological Explanations of Resistible Compulsions. American Journal of Bioethics 7 (1):15 – 17.
Eric Racine, Hz Adriaan van Der Loos & Judy Illes (2007). Internet Marketing of Neuroproducts: New Practices and Healthcare Policy Challenges. Cambridge Quarterly of Healthcare Ethics 16 (02):181-194.
Eric Racine, Sarah Waldman, Nicole Palmour, David Risse & Judy Illes (2007). “Currents of Hope”: Neurostimulation Techniques in U.S. And U.K. Print Media. Cambridge Quarterly of Healthcare Ethics 16 (03):312-316.
Citations of this work BETA
No citations found.
Similar books and articles
Stephanie Bell, Adrian Carter, Rebecca Mathews, Coral Gartner, Jayne Lucke & Wayne Hall (2014). Views of Addiction Neuroscientists and Clinicians on the Clinical Impact of a 'Brain Disease Model of Addiction'. Neuroethics 7 (1):19-27.
Maartje Schermer (2013). Health, Happiness and Human Enhancement—Dealing with Unexpected Effects of Deep Brain Stimulation. Neuroethics 6 (3):435-445.
Felicitas Kraemer (2013). Me, Myself and My Brain Implant: Deep Brain Stimulation Raises Questions of Personal Authenticity and Alienation. Neuroethics 6 (3):483-497.
Cordelia Erickson-Davis (2011). Ethical Concerns Regarding Commercialization of Deep Brain Stimulation for Obsessive Compulsive Disorder. Bioethics 26 (8):440-446.
Frederic Gilbert (2013). Deep Brain Stimulation for Treatment Resistant Depression: Postoperative Feelings of Self-Estrangement, Suicide Attempt and Impulsive–Aggressive Behaviours. Neuroethics 6 (3):473-481.
Frederic Gilbert (2012). The Burden of Normality: From 'Chronically Ill' to 'Symptom Free'. New Ethical Challenges for Deep Brain Stimulation Postoperative Treatment. Journal of Medical Ethics 8 (7):408-412.
Laura Klaming & Pim Haselager (2013). Did My Brain Implant Make Me Do It? Questions Raised by DBS Regarding Psychological Continuity, Responsibility for Action and Mental Competence. Neuroethics 6 (3):527-539.
Bennett Foddy (2011). Addicted to Food, Hungry for Drugs. Neuroethics 4 (2):79-89.
Farah Focquaert (2013). Deep Brain Stimulation in Children: Parental Authority Versus Shared Decision-Making. Neuroethics 6 (3):447-455.
Kamilla L. Venner & Michael P. Bogenschutz (2008). Cultural and Spiritual Dimensions of Addiction Treatment. In Cynthia M. A. Geppert & Laura Weiss Roberts (eds.), The Book of Ethics: Expert Guidance for Professionals Who Treat Addiction. Hazelden. 67.
Veronica Johansson, Martin Garwicz, Martin Kanje, Helena Röcklinsberg, Jens Schouenborg, Anders Tingström & Ulf Görman (2013). Beyond Blind Optimism and Unfounded Fears: Deep Brain Stimulation for Treatment Resistant Depression. Neuroethics 6 (3):457-471.
Nir Lipsman & Walter Glannon (2013). Brain, Mind and Machine: What Are the Implications of Deep Brain Stimulation for Perceptions of Personal Identity, Agency and Free Will? Bioethics 27 (9):465-470.
Hanna Pickard & Steve Pearce, Addiction in Context: Philosophical Lessons From a Personality Disorder Clinic.
Christie A. Cline & Kenneth Minkoff (2008). Ethical Issues in the Treatment of Persons with Co-Occurring Disorders. In Cynthia M. A. Geppert & Laura Weiss Roberts (eds.), The Book of Ethics: Expert Guidance for Professionals Who Treat Addiction. Hazelden.
Matthew Tieu (2010). Understanding the Nature of Drug Addiction. Bioethics Research Notes 22 (1):7.
Added to index2010-11-18
Total downloads33 ( #62,423 of 1,688,599 )
Recent downloads (6 months)3 ( #78,882 of 1,688,599 )
How can I increase my downloads?